Pemphigoid bullous

D Ambra-Cabry K, Deng DH, Flynn KL, et al. Antigen retrieval in immunofluo-rescent testing of bullous pemphigoid. Am. J. Dermatopathol. 1995 17 560-563. 

SH3 domain Kakapo, plectin, and Bullous pemphigoid antigen 1 Drosophila Kakapo (917-971) PSI-BLAST (3) 7 X 10 Human ITK Tyrosine kinase SH3... 

Possibly effective Possibly effective in the following conditions Bullous pemphigoid. 

Topical corticosteroids are most useful in inflammatory dermatoses, such as eczematous dermatitis and psoriasis they may also be helpful in other skin diseases that have a prominent inflammatory component, such as autoimmune blistering diseases (e.g., bullous pemphigoid and pemphigus vulgaris) and lupus erythematosus. 

Brown, A., Bernier, G., Mathieu, M., Rossant, J., and Kothary, R. (1995). The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nature Genet. 10, 301-306. 

Green, K. J., Virata, M. L. A., Elgart, G. W., Stanley, J. R., and Parry, D. A. D. (1992b). Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin Members of a new gene family involved in organization of intermediate filaments. Int. J. Biol. Macromol. 14, 145—153. 

Okumura, M., Yamakawa, H., Ohara, O., and Owaribe, K. (2002). Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MAGF (microtubule actin cross-linking factor). J. Biol. Chem. 277, 6682-6687. 

Sawamura, D., Li, K., Chu, M.-L., and Uitto, J. (1991). Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J. Biol. Chem. 266, 17784-17790. 

Stanley, J. R., Hawley-Nelson, P., Yuspa, S. H., Shevach, E. M., and Katz, S. I. (1981). Characterization of bullous pemphigoid antigen A unique basement membrane protein of stratified squamous epithelia. Cell 24, 897-903. 

Westgate, G. E., Weaver, A. C., and Couchman, J. R. (1985). Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes. J. Invest. Dermatol. 84, 218-224. 

Di Zenzo, G., Marazza, G., Borradori, L. (2007). Bullous pemphigoid physiopathology, clinical features and management. Adv. Dermatol. 23 257-88. 

BP180, Bullous pemphigoid antigen 2 The C-terminal 183 aa part is endostatin. 

Bullous pemphigoid frusemide (and other sulphonamide-related drugs), ACE inhibitors, penicillamine, penicillin, PUVA therapy. 

There have been numerous reports of different rashes in association with ACE inhibitors. The most common skin reaction is a pruritic maculopapular eruption, which is reportedly more common with captopril (2-7%) than with enalapril (about 1.5%). This rash occurs in the usual dosage range and is more common in patients with renal insufficiency (70). Lichenoid reactions, bullous pemphigoid, exfoliative dermatitis, flushing and erythroderma, vasculitis/purpura, subcutaneous lupus erythematosus, and reversible alopecia have aU been reported (70-72). 

Bullous pemphigoid has been attributed to bucillamine 200mg/day (10). The mouth, pharynx, larynx, and conjunctiva were involved, as well as the skin on the chest, abdomen, and axilla. Indirect immunofluorescence showed circulating antibodies against the basement membrane. 

Yamaguchi R, Oryu F, Hidano A. A case of bullous pemphigoid induced by tiobutarit (D-peniciUamine analogue). J Dermatol 1989 16(4) 308-11. 

Bullous pemphigoid induced by bumetanide has been reported (4). 

Boulinguez S, Bernard P, Bedane C, le Brim V, Bonnetblanc JM. Bullous pemphigoid induced by bumetanide. Br 1 Dermatol 1998 138(3) 548-9. 

Metals from prostheses can continue to be released into the system for many years. The development of hypersensitivity takes time, and allergic reactions are usually delayed for weeks, months, or 1-2 years. The symptoms can assume a variety of forms. Local reactions can cause loosening of the device or local pain. Dermatological reactions include eczema, bullous pemphigoid, urticaria, and muscle tumors. ... 

Ciprofloxacin can cause a fixed drug eruption (43,44), purpuric skin lesions (44,45), bullous pemphigoid (46), cutaneous vasculitis (45-47), and ultraviolet recall-like phenomenon (48). 

Kimyai-Asadi A, Usman A, Nousari HC. Ciprofloxacin-induced bullous pemphigoid. J Am Acad Dermatol 2000 42(5 Pt 1) 847. 

---